Ypsomed Holding AG (SWX:YPSN) - Share price


Stock Report

Ypsomed Holding AG YPSN

Last Price
CHF173.40

Day Change
0.00|0.00%

As of 29/11/2021
17:31:48 CET | CHF
Minimum 15 Minutes Delay.

Last Close173.40
Day Range172.00 - 176.00
Mkt Cap2.19Bil
52-Wk Range138.20 - 193.00
Yield %0.67
ISINCH0019396990
Volume5,564
P/E357.14
P/S5.13
P/CF24.32

Share Price

Financials
201920202021
More ...
Income Statement
Revenue453.77393.87403.66
Operating Income73.349.299.27
Net Income60.1411.455.81
Basic EPS4.770.910.46
Avg. Diluted Shares Outstanding131313
Balance Sheet
Current Assets178.79186.39185.14
Non Current Assets408.96488.35532.54
Total Assets587.75674.74717.68
Current Liabilities187.88274.99272.38
Total Liabilities---
Total Equity378.80375.17395.39
Cash Flow
Operating Cash Flow59.8649.0985.83
Capital Expenditure-129.05-118.73-126.58
Free Cash Flow-69.19-69.64-40.75

In millions, except "Basic EPS". Currency is CHF.

Company Profile

Ypsomed Holding AG develops and manufactures injection and infusion systems for self-medication, as well as diabetes products. The firm supplies pens, autoinjectors, and infusion systems used for liquid drugs to pharmaceutical and biotechnology companies. Ypsomed operates in three segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and others. The Ypsomed Delivery Systems segment contributes the largest proportion of revenue and sells pen systems, pen needles, and infusion sets. The diabetes direct business sells supplies for diabetes care, such as blood glucose monitors and infusion pumps. Ypsomed generates the majority of its revenue in Europe.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Stock Style

Small-Blend

Fiscal Year Ends

March

Employees

1,900
Key Stats
More ...
Price/Earning TTM353.88
Price/Book5.70
Price/Sales TTM5.13
Rev Growth (3 year avg)-4.68
EPS Growth (3 year avg)-
Operating Margin % TTM2.30
Net Margin % TTM1.44
ROE TTM1.51
Debt/Equity0.08
Dividends
PreviousLatest
More ...
Declared Date27/05/2026/05/21
Ex-Div08/07/2007/07/21
Paid10/07/2009/07/21
Amnt0.201.16
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.